Biocompatibility To Widen Scope Of Biomaterial Applications

TECH SPACE

illustration only

Palo Alto CA (SPX) Jun 22, 2004
Researchers across the world are working toward biocompatibility by optimizing interactions that occur between implanted biomaterials and the host living tissue. Overcoming this significant technical challenge is likely to broaden the scope of biomaterials' applications.

"Thrombosis involving blood coagulation and adhesion of blood platelets to biomaterial surfaces as well as fibrous-tissue encapsulation of biomaterials that are implanted in soft tissues are two challenging issues for researchers in quest of biocompatibility," says Technical Insights Analyst Dr. James Smith.

Biocompatibility assumes greater significance as surgeons are increasingly focusing on treatment of chronic diseases.

For instance, spinal surgeons are turning their attention to technologies that can treat chronic back pain rather than focusing on achieving spinal stability, as fusion technology such as cages, bone grafts, and fixation devices attain maturity in terms of providing positive clinical benefits.

Growing understanding of complex biological materials and development of novel biomaterials designed at the molecular level to meet specific medical applications are likely to mark future advancements toward biocompatibility.

One such development is tailor-made, designer polymers from a beaker by programming the modular polymer scaffolds to attract building blocks of small molecules. This 'one-beaker' process aims at simplifying the synthesis of designer polymers through self-assembly using combinatorial chemistry.

Researchers have used the same 'one-beaker' principle to build copolymers and modify properties of polymers by changing certain variables such as temperature, pH factor, ultraviolet light, and solvents.

Other exciting research prospects include the development of customized organic polymers that can be used to regenerate damaged nerves. Research on visual prostheses promises to restore vision for blind individuals by way of retinal implants.

However, researchers may have to face long periods of product testing, product cycle, and clinician acceptance while countering reimbursement issues before successful commercialization.

"The efforts of researchers are hampered by the current liability laws and stringent functioning of the Food and Drug Administration (FDA) in certifying the safety and effectiveness of the medical devices based on the results of clinical trials," informs Smith.

However, the FDA's conservative policy and demand for comprehensive documentation is understandable, as medical device manufacturers can be subject to liability lawsuits even after obtaining governmental approval.

TECH SPACE

NASA And Xerox Announce Technology Partnership

Moffett Field (SPX) Jun 09, 2004
NASA and Xerox are forming a new technology partnership in which the Stamford, Conn., company will help NASA develop state-of-the-art collaboration and knowledge management systems, while providing new tools and applications to help NASA implement the Vision for Space Exploration.

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

The content herein, unless otherwise known to be public domain, are Copyright 1995-2016 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement All images and articles appearing on Space Media Network have been edited or digitally altered in some way. Any requests to remove copyright material will be acted upon in a timely and appropriate manner. Any attempt to extort money from Space Media Network will be ignored and reported to Australian Law Enforcement Agencies as a potential case of financial fraud involving the use of a telephonic carriage device or postal service.